- Home
- GTN vs TRDA Comparison
GTN vs TRDA Comparison
Compare GTN & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTN
- TRDA
- Stock Information
- Founded
- GTN 1897
- TRDA 2016
- Country
- GTN United States
- TRDA United States
- Employees
- GTN N/A
- TRDA N/A
- Industry
- GTN Broadcasting
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- GTN Industrials
- TRDA Health Care
- Exchange
- GTN Nasdaq
- TRDA Nasdaq
- Market Cap
- GTN 491.0M
- TRDA 502.9M
- IPO Year
- GTN N/A
- TRDA 2021
- Fundamental
- Price
- GTN $3.36
- TRDA $8.89
- Analyst Decision
- GTN Strong Buy
- TRDA Strong Buy
- Analyst Count
- GTN 3
- TRDA 3
- Target Price
- GTN $6.33
- TRDA $25.67
- AVG Volume (30 Days)
- GTN 1.4M
- TRDA 173.0K
- Earning Date
- GTN 05-08-2025
- TRDA 05-06-2025
- Dividend Yield
- GTN 9.82%
- TRDA N/A
- EPS Growth
- GTN N/A
- TRDA N/A
- EPS
- GTN 3.36
- TRDA 1.68
- Revenue
- GTN $3,644,000,000.00
- TRDA $210,782,000.00
- Revenue This Year
- GTN N/A
- TRDA N/A
- Revenue Next Year
- GTN $14.86
- TRDA N/A
- P/E Ratio
- GTN $0.97
- TRDA $5.15
- Revenue Growth
- GTN 11.06
- TRDA 63.38
- 52 Week Low
- GTN $2.91
- TRDA $7.10
- 52 Week High
- GTN $7.41
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- GTN 33.99
- TRDA 49.71
- Support Level
- GTN $3.13
- TRDA $7.56
- Resistance Level
- GTN $3.47
- TRDA $8.38
- Average True Range (ATR)
- GTN 0.24
- TRDA 0.64
- MACD
- GTN -0.06
- TRDA 0.20
- Stochastic Oscillator
- GTN 9.84
- TRDA 94.06
About GTN Gray Television Inc.
Gray Media Inc is a multimedia company. The company owns and operates local television stations and digital assets. It also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with digital products and services. Its additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.